Home/All Molecules/Risperidone

Risperidone Range

Comprehensive Risperidone portfolio for Franchise & Manufacturing.

Category
risperidone
Total Formulations
9
Available Forms
Syrup, Tablets

Expand Your Business with Our Multiple Divisions


Browse Risperidone portfolio by Dosage Form


The Cafoli Advantage for PCD Franchise & Manufacturing

WHO-GMP Quality

Every Risperidone batch undergoes rigorous in-house and third-party testing, strictly adhering to WHO-GMP standards for efficacy and safety.

Quality Policy

Monopoly & Branding

Secure exclusive PCD franchise rights for your territory and benefit from our range of premium, marketing-driven product packaging.

Market Strategy

Sales Support

Enhance your sales with Cafoli’s complete kit of marketing materials, including visual aids, MR bags, catch covers, and product cards.

Marketing Tools

Risperidone PCD Pharma Franchise Company

Risperidone PCD Pharma Franchise Company

Cafoli Lifecare is a trusted Risperidone PCD pharma franchise company offering 9 WHO-GMP certified Risperidone formulations. We provide district-wise monopoly rights, quality-assured products and complete promotional support to pharma distributors, franchise partners and marketing professionals across India.

What is Risperidone?

Risperidone is a second-generation (atypical) antipsychotic that blocks dopamine D2 and serotonin 5-HT2A receptors, helping to control psychotic symptoms and stabilise mood. It is a prescription-only medicine. Reference data is available on PubChem.

Available Risperidone Formulations

Our Risperidone portfolio spans 9 formulations available in Syrup and Tablet forms. This range lets franchise partners serve multiple prescriber and patient segments from a single dependable supplier, with consistent quality across every batch.

Therapeutic Applications

Risperidone is indicated for schizophrenia, acute manic episodes of bipolar disorder and irritability associated with autism spectrum disorder. It is prescribed and supervised by psychiatrists, with the syrup form useful for paediatric and dose-flexible use.

Why Risperidone is a High-Potential Molecule for Distributors

Availability in both syrup and tablet forms lets partners serve adult and paediatric psychiatry from one supplier, and chronic use drives dependable repeat prescriptions. Growing recognition and treatment of psychiatric and developmental disorders across India supports sustained Risperidone demand.

Why Choose Cafoli Lifecare

As a WHO-GMP certified and DCGI-approved pharma company, Cafoli Lifecare gives franchise partners district-wise monopoly rights, quality-assured products, attractive margins and complete promotional inputs including visual aids, product cards and marketing support. With a network of 1000+ partners across India, we combine dependable supply with genuine on-ground support to help you grow.

References

  1. PubChem - Risperidone
  2. PubMed - Risperidone clinical literature

Aceclofenac in Modern Clinical Practice

Our formulations of Risperidone find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to:


FAQ about Risperidone in PCD Franchise

Start Your Risperidone Franchise with Cafoli Lifecare

Ready to launch your Risperidone PCD pharma franchise with monopoly rights and full promotional support? Call +91 95184 47302 or email info@cafoli.in to get started.

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions (FAQs)

Cafoli Lifecare offers 9 WHO-GMP certified Risperidone formulations across syrup and tablet forms for adult and paediatric psychiatry.

Yes. We grant district-wise monopoly rights so each franchise partner markets Risperidone exclusively within their allotted territory.

Risperidone is prescribed mainly by psychiatrists, including child and adolescent psychiatrists managing autism-related irritability.

The syrup form allows flexible, precise dosing that is helpful for children and patients who cannot swallow tablets. Risperidone is a prescription-only medicine and must be used under psychiatric supervision.

A valid Drug License and GST registration are required to appoint a Risperidone PCD franchise with Cafoli Lifecare.